通过对347例家族性和早发性病例进行外显子组测序鉴定推定多发性骨髓瘤易感基因
研究对法国、瑞典和希腊128个家族的177例受累个体及170例55岁前诊断的早发性多发性骨髓瘤病例进行外显子组测序,聚焦罕见种系蛋白截短和可能有害错义变异,鉴定出ATM(N=12)、ANGPTL6(N=5)和FBXW9(N=6)的可能致病变异,并在既往报道的易感基因DIS3、EP300和KDM1A中检出变异。
要点
- 128个家族177例受累个体及170例早发性多发性骨髓瘤病例接受外显子组测序。
- 鉴定出ATM(N=12)、ANGPTL6(N=5)和FBXW9(N=6)的可能致病变异。
- 在DIS3、EP300和KDM1A等既往报道的易感基因中亦检出变异。
核心结论
- 研究结果为迄今针对家族性和早发性多发性骨髓瘤的最大规模测序研究,进一步阐明多发性骨髓瘤的体质性遗传基础。
研究设计与样本
- 对来自法国、瑞典和希腊128个家族的177例受累个体及170例55岁前诊断的早发性多发性骨髓瘤病例进行外显子组测序。
- 分析聚焦于在至少两个显示变异-疾病共分离的家族中出现的基因,以及额外索引病例(≥2例)和/或早发性病例(≥2例)中的罕见种系蛋白截短变异和可能有害错义变异。
主要发现
- 鉴定出ATM(N=12)、ANGPTL6(N=5)和FBXW9(N=6)的可能致病变异。
- 在既往报道的多发性骨髓瘤易感基因DIS3、EP300和KDM1A中检出变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is the second most common blood malignancy, with several lines of evidence supporting an inherited genetic component. Here, we sequenced 177 affected individuals from 128 families, and 170 early-onset MM cases diagnosed before 55 years of age. Samples were identified and collected through nationwide efforts in France, Sweden, and Greece. We focused on rare germline protein truncating and likely deleterious missense variants in genes harboring variants in at least two families showing variant-disease segregation, and in additional index (≥2) and/or early-onset (≥2) cases. We identified likely pathogenic variants in ATM (N = 12), ANGPTL6 (N = 5), and FBXW9 (N = 6). Additionally, we detected variants in previously reported MM predisposition genes, including DIS3, EP300, and KDM1A. Our results represent the largest sequencing study on familial and early-onset MM to date, and further illuminate the constitutional genetic basis of MM.
引用
- Pertesi M, Demangel D, Niroula A, et al. Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases. Leukemia. 2025. PMID: 41254116. doi:10.1038/s41375-025-02802-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。